Suppr超能文献

维生素D与黑色素瘤

Vitamin D and melanoma.

作者信息

Field Sinead, Davies John, Bishop D Tim, Newton-Bishop Julia A

机构信息

Section of Epidemiology and Biostatistics; University of Leeds; Leeds, UK.

出版信息

Dermatoendocrinol. 2013 Jan 1;5(1):121-9. doi: 10.4161/derm.25244.

Abstract

Recreational sun exposure and sunburn are causal for melanoma but the risk is strongly genetically determined. Health promotion advice about sun protection should be aimed at susceptible individuals (pale skin, freckles, large numbers of melanocytic nevi and a family history). We discuss here the evidence that sun-sensitive people have lower vitamin D levels and that, in practice, it is very difficult for such individuals to achieve sufficient levels without supplementation in the UK at least. We conclude that melanoma susceptible sun-avoidant individuals should be advised to avoid insufficiency by supplementation. Vitamin D is anti-proliferative in vitro for some melanoma cell lines. In a large melanoma cohort we have observed that lower serum 25-hydroxyvitamin D2/D3 levels at diagnosis were associated with thicker tumors and poorer prognosis (study as yet not validated). In the UK, melanoma patients commonly have sub-optimal 25-hydroxyvitamin D2/D3 levels at and post diagnosis; we discuss approaches to management of such patients based on some new data from our group.

摘要

休闲时晒太阳及晒伤是黑色素瘤的病因,但风险在很大程度上由基因决定。关于防晒的健康促进建议应针对易感个体(肤色浅、有雀斑、大量黑素细胞痣及家族病史者)。我们在此讨论以下证据:对阳光敏感的人群维生素D水平较低,并且实际上,至少在英国,这类个体不进行补充很难达到充足水平。我们得出结论,应建议易患黑色素瘤且避免晒太阳的个体通过补充来避免维生素D不足。维生素D在体外对某些黑色素瘤细胞系具有抗增殖作用。在一个大型黑色素瘤队列中,我们观察到诊断时血清25-羟基维生素D2/D3水平较低与肿瘤较厚及预后较差相关(该研究尚未得到验证)。在英国,黑色素瘤患者在诊断时及诊断后25-羟基维生素D2/D3水平通常不理想;我们根据我们团队的一些新数据讨论对此类患者的管理方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/335e/3897580/48076516ce62/de-5-121-g1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验